<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04152044</url>
  </required_header>
  <id_info>
    <org_study_id>SJH00003</org_study_id>
    <nct_id>NCT04152044</nct_id>
  </id_info>
  <brief_title>Obesity and Liver Function in Oesophageal Cancer</brief_title>
  <official_title>Elucidating the Role of Obesity, Liver Function and Pathology With Overall Outcomes in Oesophageal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. James's Hospital, Ireland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. James's Hospital, Ireland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is an established link between sarcopenia and outcomes in oesophageal cancer. There is
      scant reports in the literature regarding the influences of different obesity in different
      compartments.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Oesophageal cancer rates are increasing as a result of obesity in Western society. Thr
      investigators are evaluating the influence of viscerala dn subcutaneous obesity on overall
      outcomes of the participants. In addition the investigators are evaluating if there is a
      correlation with Liver Function Tests and liver histopathology such as steatosis on survival
      in participants and post operative sequele.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2019</start_date>
  <completion_date type="Anticipated">November 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Disease free survival</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">658</enrollment>
  <condition>Obesity</condition>
  <condition>Liver Function</condition>
  <arm_group>
    <arm_group_label>Liver biopsy, Visceral and subcutaneous obesity</arm_group_label>
    <description>Those with histology and LFT's and quantificaiton of obesity</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation of different types of obesity and liver pathology in patients undergoing and oesophagectomy</intervention_name>
    <description>Patinets undergoing surgery</description>
    <arm_group_label>Liver biopsy, Visceral and subcutaneous obesity</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        oesophageal cancer patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Those undergoing oesophagectomy

        Exclusion Criteria:

          -  patients who only had chemotherapy/chemoradiotherapy without surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Noel E Donlon</last_name>
    <phone>00353863557726</phone>
    <phone_ext>00353863557726</phone_ext>
    <email>donlonn@tcd.ie</email>
  </overall_contact>
  <location>
    <facility>
      <name>St. James's Hospital</name>
      <address>
        <city>Dublin</city>
        <state>IE</state>
        <zip>D8</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noel E Donlon</last_name>
      <phone>00353863557726</phone>
      <phone_ext>00353863557726</phone_ext>
      <email>donlonn@tcd.ie</email>
    </contact>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 2, 2019</study_first_submitted>
  <study_first_submitted_qc>November 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2019</study_first_posted>
  <last_update_submitted>November 2, 2019</last_update_submitted>
  <last_update_submitted_qc>November 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. James's Hospital, Ireland</investigator_affiliation>
    <investigator_full_name>Noel Edward Donlon</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

